Videos

Biocon Completes Acquisition of Viatris’ Global Biosimilars Business

Creates an integrated, leading global biosimilars enterprise with eight commercialized products.

By: Kristin Brooks

Managing Editor, Contract Pharma


Keep Up With Our Content. Subscribe To Contract Pharma Newsletters